Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > DR DR - PART TIME CEO?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(13)
•••
Comment by narmacon Nov 29, 2020 10:19am
216 Views
Post# 31996520

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DR DR - PART TIME CEO?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:DR DR - PART TIME CEO?Hummm,,,for me it will be DrDRs ability to meet the timeline and or pull it forward for the XB3-001 HER2 Brain Cancer Metastasis trial. All side deals is additional gravy for us. We are looking out to sometime in the first quarter of '22 for Phase l. I am hoping this date does not slide more.

Companies having the same CEO is more common than one knows. One doesn't have to look far to find at least one other close to heart.






<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities